Does TAMOXIFEN Cause Product formulation issue? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Product formulation issue have been filed in association with TAMOXIFEN (Tamoxifen Citrate). This represents 0.1% of all adverse event reports for TAMOXIFEN.
8
Reports of Product formulation issue with TAMOXIFEN
0.1%
of all TAMOXIFEN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product formulation issue From TAMOXIFEN?
Of the 8 reports.
Is Product formulation issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAMOXIFEN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TAMOXIFEN Cause?
Malignant neoplasm progression (1,499)
Metastases to bone (894)
Fatigue (729)
Nausea (611)
Metastases to liver (595)
Breast cancer (584)
Disease progression (571)
Breast cancer metastatic (515)
Diarrhoea (512)
Arthralgia (497)
What Other Drugs Cause Product formulation issue?
MINOXIDIL (1,369)
LEVOTHYROXINE (740)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (174)
OMEPRAZOLE (99)
METHYLPHENIDATE (78)
OXYCODONE (73)
ACETAMINOPHEN\HYDROCODONE (62)
ACETAMINOPHEN\OXYCODONE (61)
ACETAMINOPHEN (59)
BUPROPION (59)
Which TAMOXIFEN Alternatives Have Lower Product formulation issue Risk?
TAMOXIFEN vs TAMSULOSIN
TAMOXIFEN vs TAPENTADOL
TAMOXIFEN vs TAPINAROF
TAMOXIFEN vs TARCEVA
TAMOXIFEN vs TARLATAMAB